155 related articles for article (PubMed ID: 34845270)
1. Expression and purification of a native Thy1-single-chain variable fragment for use in molecular imaging.
Jugniot N; Bam R; Paulmurugan R
Sci Rep; 2021 Nov; 11(1):23026. PubMed ID: 34845270
[TBL] [Abstract][Full Text] [Related]
2. Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma.
Bam R; Daryaei I; Abou-Elkacem L; Vilches-Moure JG; Meuillet EJ; Lutz A; Marinelli ER; Unger EC; Gambhir SS; Paulmurugan R
Invest Radiol; 2020 Nov; 55(11):711-721. PubMed ID: 32569010
[TBL] [Abstract][Full Text] [Related]
3. Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
Abou-Elkacem L; Wang H; Chowdhury SM; Kimura RH; Bachawal SV; Gambhir SS; Tian L; Willmann JK
Clin Cancer Res; 2018 Apr; 24(7):1574-1585. PubMed ID: 29301827
[No Abstract] [Full Text] [Related]
4. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
Sarker A; Rathore AS; Gupta RD
Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
[TBL] [Abstract][Full Text] [Related]
5. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
Sharma SK; Suresh MR; Wuest FR
Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
[TBL] [Abstract][Full Text] [Related]
6. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.
Foygel K; Wang H; Machtaler S; Lutz AM; Chen R; Pysz M; Lowe AW; Tian L; Carrigan T; Brentnall TA; Willmann JK
Gastroenterology; 2013 Oct; 145(4):885-894.e3. PubMed ID: 23791701
[TBL] [Abstract][Full Text] [Related]
7. Production of Stabilized Antibody Fragments in the E. coli Bacterial Cytoplasm and in Transiently Transfected Mammalian Cells.
Birnboim-Perach R; Grinberg Y; Vaks L; Nahary L; Benhar I
Methods Mol Biol; 2019; 1904():455-480. PubMed ID: 30539486
[TBL] [Abstract][Full Text] [Related]
8. Production of stabilized scFv antibody fragments in the E. coli bacterial cytoplasm.
Vaks L; Benhar I
Methods Mol Biol; 2014; 1060():171-84. PubMed ID: 24037842
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
Bu D; Zhou Y; Tang J; Jing F; Zhang W
Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
[TBL] [Abstract][Full Text] [Related]
10. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system.
Moricoli D; Muller WA; Carbonella DC; Balducci MC; Dominici S; Watson R; Fiori V; Weber E; Cianfriglia M; Scotlandi K; Magnani M
J Immunol Methods; 2014 Jun; 408():35-45. PubMed ID: 24798881
[TBL] [Abstract][Full Text] [Related]
11. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector.
Zhao Q; Chan YW; Lee SS; Cheung WT
Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of in vitro refolding vs cold shock expression: Production of a low yielding single chain variable fragment.
Vermeulen JG; Burt F; van Heerden E; Cason E; Meiring M
Protein Expr Purif; 2018 Nov; 151():62-71. PubMed ID: 29894804
[TBL] [Abstract][Full Text] [Related]
13. Purification and refolding of anti-T-antigen single chain antibodies (scFvs) expressed in Escherichia coli as inclusion bodies.
Yuasa N; Koyama T; Fujita-Yamaguchi Y
Biosci Trends; 2014 Feb; 8(1):24-31. PubMed ID: 24647109
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.
Gupta V; Sudhakaran IP; Islam Z; Vaikath NN; Hmila I; Lukacsovich T; Kolatkar PR; El-Agnaf OMA
PLoS One; 2020; 15(11):e0241773. PubMed ID: 33156828
[TBL] [Abstract][Full Text] [Related]
15. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
16. Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in
Byun KT; Kim B; Cho J; Lee I; Lee MG; Park D; Kang TB; Won HS; Kim CG
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892190
[TBL] [Abstract][Full Text] [Related]
17. A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies.
Sun W; Xie J; Lin H; Mi S; Li Z; Hua F; Hu Z
Protein Expr Purif; 2012 May; 83(1):21-9. PubMed ID: 22387083
[TBL] [Abstract][Full Text] [Related]
18. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
[TBL] [Abstract][Full Text] [Related]
19. Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner.
Liu M; Wang B; Wang F; Yang Z; Gao D; Zhang C; Ma L; Yu X
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6071-6079. PubMed ID: 31175428
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the efficacy of immobilized metal affinity chromatography (IMAC) for host cell protein (HCP) removal from anti-HER2 scFv expressed in Escherichia coli.
Soltaninasab S; Ahmadzadeh M; Shahhosseini S; Mohit E
Protein Expr Purif; 2022 Feb; 190():106004. PubMed ID: 34688918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
